These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 31004679)
1. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients. Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679 [TBL] [Abstract][Full Text] [Related]
2. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis. Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients. He D; Liu M; Liu B Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585 [TBL] [Abstract][Full Text] [Related]
4. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N Lupus; 2022 Jan; 31(1):55-64. PubMed ID: 34978958 [TBL] [Abstract][Full Text] [Related]
5. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus. Badr AMM; Farag Y; Abdelshafy M; Riad NM Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928 [TBL] [Abstract][Full Text] [Related]
7. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis. Xia LP; Li BF; Shen H; Lu J Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331 [TBL] [Abstract][Full Text] [Related]
9. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
10. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus. Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413 [TBL] [Abstract][Full Text] [Related]
12. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment. Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832 [TBL] [Abstract][Full Text] [Related]
13. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients. Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I Front Immunol; 2020; 11():582737. PubMed ID: 33133102 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus. Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis. Rahmé Z; Franco C; Cruciani C; Pettorossi F; Zaramella A; Realdon S; Iaccarino L; Frontini G; Moroni G; Doria A; Ghirardello A; Gatto M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834330 [TBL] [Abstract][Full Text] [Related]
16. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis. Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750 [TBL] [Abstract][Full Text] [Related]
17. Serum thiols as a biomarker of disease activity in lupus nephritis. Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079 [TBL] [Abstract][Full Text] [Related]
18. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis. Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762 [TBL] [Abstract][Full Text] [Related]
19. IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. Zickert A; Amoudruz P; Sundström Y; Rönnelid J; Malmström V; Gunnarsson I BMC Immunol; 2015 Feb; 16(1):7. PubMed ID: 25887118 [TBL] [Abstract][Full Text] [Related]
20. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]